Funded Tech Companies
GenEdit
GenEdit is a leading biopharmaceutical company, located in San Francisco. VC investment came from Eli Lilly and Company, Korea Investment Partners and Mirae Asset Venture Investment.
Company Overview
Company Name
GenEdit
Company Status
Private & Independent
Industry
Funding Rounds
Total Funding
Contact Information
Mailing Address
681 Gateway Blvd. 3rd Foor
San Francisco, CA 94080
USA
San Francisco, CA 94080
USA
Phone
Undisclosed
Website
Email Address
Not Recorded
Company Background Information
Overview
GenEdit is a next-generation genome editing company. We are developing non-viral delivery technologies for the CRISPR/Cas9 gene editing system that can safely and efficiently correct gene mutations in patients.
Profile
Social Media
Company News
Facebook
YouTube
Last Transaction
1/23/2024
Financing History
Date
Type
Amount
Management Team
Title
Name
Email & Social
Chief Executive Officer
Kunwoo Lee
Chief Financial Officer
Aaron Mishel
Chief Scientific Officer
Romuald Corbau
Chief Technical Officer
Timothy Fong
Vice President
Yvonne Angell
Vice President
Derek Sloan
VP - Bus. Development
Jennifer Cygan
VP - Operations
Hyo Park
Company Investors
- Eli Lilly and Company (Andrew Adams)
- Korea Investment Partners
- Mirae Asset Venture Investment
- Terra Venture Partners
- KB Investment
- Kimco Realty Corporation
- IMM Investment
- LoftyRock Investment
- K2 Investment Partners
- Huons
- DAYLI Partners
- ACVC Partners
- Pathway Bioventures
- Woori Venture Partners
- Dong-A ST
- Sequoia Capital
- KDB Industrial Bank
- Timefolio Asset Management
- SK Holdings (Jinsoo Lee)
- Bow Capital
- Data Collective (Kiersten Stead)
- KB Partners
- Company K Partners
- KTB Network
Browse more funded tech companies:
Share this article
About Our Venture Capital Database
This venture capital transaction data comes via a partnership with VentureDeal.com, a leading provider of venture capital transaction data.
Additional Resources for Entrepreneurs